vs

Side-by-side financial comparison of Cardlytics, Inc. (CDLX) and OCTAVE SPECIALTY GROUP INC (OSG). Click either name above to swap in a different company.

OCTAVE SPECIALTY GROUP INC is the larger business by last-quarter revenue ($66.9M vs $50.9M, roughly 1.3× Cardlytics, Inc.). On growth, OCTAVE SPECIALTY GROUP INC posted the faster year-over-year revenue change (2.6% vs -25.5%). Over the past eight quarters, OCTAVE SPECIALTY GROUP INC's revenue compounded faster (16.2% CAGR vs -9.6%).

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

Octave Specialty Group Inc. is a specialty insurance holding company that provides tailored property and casualty insurance products. Its core business focuses on excess and surplus lines, catering to commercial and individual clients across primary North American markets with customized risk coverage solutions.

CDLX vs OSG — Head-to-Head

Bigger by revenue
OSG
OSG
1.3× larger
OSG
$66.9M
$50.9M
CDLX
Growing faster (revenue YoY)
OSG
OSG
+28.0% gap
OSG
2.6%
-25.5%
CDLX
Faster 2-yr revenue CAGR
OSG
OSG
Annualised
OSG
16.2%
-9.6%
CDLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDLX
CDLX
OSG
OSG
Revenue
$50.9M
$66.9M
Net Profit
$-29.7M
Gross Margin
Operating Margin
-12.0%
-76.7%
Net Margin
-73.8%
Revenue YoY
-25.5%
2.6%
Net Profit YoY
-41.7%
EPS (diluted)
$-0.15
$-0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDLX
CDLX
OSG
OSG
Q4 25
$50.9M
$66.9M
Q3 25
$47.0M
$66.6M
Q2 25
$58.0M
$55.0M
Q1 25
$56.4M
$62.8M
Q4 24
$68.3M
$65.2M
Q3 24
$61.1M
$70.0M
Q2 24
$64.0M
$51.0M
Q1 24
$62.2M
$49.6M
Net Profit
CDLX
CDLX
OSG
OSG
Q4 25
$-29.7M
Q3 25
$-72.7M
$-112.6M
Q2 25
$-9.3M
$-72.7M
Q1 25
$-13.3M
$-44.7M
Q4 24
$-20.9M
Q3 24
$-145.2M
$-27.5M
Q2 24
$-4.3M
$-750.0K
Q1 24
$-24.3M
$20.8M
Operating Margin
CDLX
CDLX
OSG
OSG
Q4 25
-12.0%
-76.7%
Q3 25
-146.6%
-48.2%
Q2 25
-22.0%
-41.8%
Q1 25
-24.9%
-24.1%
Q4 24
-12.2%
-55.5%
Q3 24
-243.1%
-29.7%
Q2 24
-24.7%
-28.9%
Q1 24
-36.7%
-6.5%
Net Margin
CDLX
CDLX
OSG
OSG
Q4 25
-73.8%
Q3 25
-154.7%
-169.1%
Q2 25
-16.0%
-132.3%
Q1 25
-23.5%
-71.3%
Q4 24
-55.1%
Q3 24
-237.6%
-39.3%
Q2 24
-6.7%
-1.5%
Q1 24
-39.0%
41.9%
EPS (diluted)
CDLX
CDLX
OSG
OSG
Q4 25
$-0.15
$-0.82
Q3 25
$-1.36
$-2.35
Q2 25
$-0.18
$-1.54
Q1 25
$-0.26
$-1.22
Q4 24
$-0.36
$-11.75
Q3 24
$-2.90
$-0.63
Q2 24
$-0.09
$-0.02
Q1 24
$-0.56
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDLX
CDLX
OSG
OSG
Cash + ST InvestmentsLiquidity on hand
$48.7M
$146.4M
Total DebtLower is stronger
$212.6M
$117.6M
Stockholders' EquityBook value
$-6.5M
$715.8M
Total Assets
$285.6M
$2.2B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDLX
CDLX
OSG
OSG
Q4 25
$48.7M
$146.4M
Q3 25
$44.0M
$27.5M
Q2 25
$46.7M
$22.5M
Q1 25
$52.0M
$34.1M
Q4 24
$65.6M
$157.2M
Q3 24
$67.0M
$40.8M
Q2 24
$71.2M
$14.6M
Q1 24
$97.8M
$13.8M
Total Debt
CDLX
CDLX
OSG
OSG
Q4 25
$212.6M
$117.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
$0
Q3 24
$213.2M
$518.0M
Q2 24
$212.9M
$515.0M
Q1 24
$257.9M
$512.0M
Stockholders' Equity
CDLX
CDLX
OSG
OSG
Q4 25
$-6.5M
$715.8M
Q3 25
$-4.7M
$843.4M
Q2 25
$58.7M
$859.8M
Q1 25
$64.1M
$852.2M
Q4 24
$70.0M
$798.4M
Q3 24
$69.7M
$1.5B
Q2 24
$210.0M
$1.4B
Q1 24
$199.1M
$1.4B
Total Assets
CDLX
CDLX
OSG
OSG
Q4 25
$285.6M
$2.2B
Q3 25
$292.8M
$2.1B
Q2 25
$361.1M
$8.5B
Q1 25
$369.1M
$8.3B
Q4 24
$392.7M
$8.1B
Q3 24
$399.4M
$9.3B
Q2 24
$534.4M
$8.2B
Q1 24
$569.0M
$8.4B
Debt / Equity
CDLX
CDLX
OSG
OSG
Q4 25
0.16×
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
0.00×
Q3 24
3.06×
0.35×
Q2 24
1.01×
0.38×
Q1 24
1.29×
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDLX
CDLX
OSG
OSG
Operating Cash FlowLast quarter
$13.0M
$-52.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDLX
CDLX
OSG
OSG
Q4 25
$13.0M
$-52.3M
Q3 25
$1.8M
$-41.2M
Q2 25
$1.2M
$2.1M
Q1 25
$-6.7M
$-12.6M
Q4 24
$3.0M
$762.0K
Q3 24
$1.4M
$48.9M
Q2 24
$4.4M
$20.4M
Q1 24
$-17.6M
$7.1M
Free Cash Flow
CDLX
CDLX
OSG
OSG
Q4 25
$13.0M
Q3 25
$1.7M
Q2 25
$903.0K
Q1 25
$-6.8M
Q4 24
$2.9M
Q3 24
$878.0K
Q2 24
$4.1M
Q1 24
$-18.3M
FCF Margin
CDLX
CDLX
OSG
OSG
Q4 25
25.5%
Q3 25
3.7%
Q2 25
1.6%
Q1 25
-12.1%
Q4 24
4.2%
Q3 24
1.4%
Q2 24
6.5%
Q1 24
-29.4%
Capex Intensity
CDLX
CDLX
OSG
OSG
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.6%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.8%
Q2 24
0.4%
Q1 24
1.0%
Cash Conversion
CDLX
CDLX
OSG
OSG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDLX
CDLX

Segment breakdown not available.

OSG
OSG

Other$28.7M43%
Specialty Property Casualty Program$23.1M34%
Accident Health$9.6M14%
Specialty Automobile$3.1M5%
Niche Specialty Risks$2.4M4%

Related Comparisons